These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2732688)

  • 1. In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera.
    Gimenez HB; Keir HM; Cash P
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():89-96. PubMed ID: 2732688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The response of infants with bronchiolitis to the proteins of respiratory syncytial virus.
    Levine S; Dajani A; Klaiber-Franco R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1229-39. PubMed ID: 3385405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.
    Ward KA; Lambden PR; Ogilvie MM; Watt PJ
    J Gen Virol; 1983 Sep; 64 (Pt 9)():1867-76. PubMed ID: 6886679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model.
    Ponnuraj EM; Springer J; Hayward AR; Wilson H; Simoes EA
    J Infect Dis; 2003 Apr; 187(8):1257-63. PubMed ID: 12696005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoblot analysis of the human antibody response to respiratory syncytial virus infection.
    Gimenez HB; Keir HM; Cash P
    J Gen Virol; 1987 May; 68 ( Pt 5)():1267-75. PubMed ID: 3572364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of respiratory syncytial virus after cell attachment.
    Osiowy C; Anderson R
    J Virol; 1995 Feb; 69(2):1271-4. PubMed ID: 7815504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing and enhancing activities of human respiratory syncytial virus-specific antibodies.
    Gimenez HB; Chisholm S; Dornan J; Cash P
    Clin Diagn Lab Immunol; 1996 May; 3(3):280-6. PubMed ID: 8705669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cell-dependent lysis of respiratory syncytial virus-infected cells mediated by antibody from local respiratory secretions.
    Cranage MP; Gardner PS; McIntosh K
    Clin Exp Immunol; 1981 Jan; 43(1):28-35. PubMed ID: 7018759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity.
    Palomo C; García-Barreno B; Peñas C; Melero JA
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():669-75. PubMed ID: 2005433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection.
    Schlesinger JJ; Brandriss MW
    J Immunol; 1981 Aug; 127(2):659-65. PubMed ID: 7252155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus.
    Scott R; de Landazuri MO; Gardner PS; Owen JJ
    Clin Exp Immunol; 1977 Apr; 28(1):19-26. PubMed ID: 862248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to respiratory syncytial virus: prevention of syncytia formation by human serum during in vitro infection.
    Faden H; Lin T; Hong JJ; Ogra PL
    Pediatr Res; 1984 Oct; 18(10):987-91. PubMed ID: 6387611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein.
    Samson AC; Willcocks MM; Routledge EG; Morgan LA; Toms GL
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1479-83. PubMed ID: 3755162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of complement and viral filtration on the neutralization of respiratory syncytial virus.
    Baughman RH; Fenters JD; Marquis GS; Holper JC
    Appl Microbiol; 1968 Jul; 16(7):1076-80. PubMed ID: 5664124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to respiratory syncytial virus: detection of virus neutralization and other antigen-antibody systems using infected human and murine cells.
    Cote PJ; Fernie BF; Ford EC; Shih JW; Gerin JL
    J Virol Methods; 1981 Oct; 3(3):137-47. PubMed ID: 7298794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of bovine respiratory syncytial virus infection by complement fixation test.
    Takahasi E; Inaba Y; Kurogi H; Sato K; Goto Y
    Natl Inst Anim Health Q (Tokyo); 1975; 15(4):179-85. PubMed ID: 174010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection.
    Gaddum RM; Cook RS; Wyld SG; López JA; Bustos R; Melero JA; Taylor G
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1239-48. PubMed ID: 8683212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies.
    Sullender WM; Edwards KG
    Virology; 1999 Nov; 264(1):230-6. PubMed ID: 10544149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.